From the blog

Glypican-1 Expression in Epithelioid Mesothelioma, Adenocarcinoma and SCC of the Lung

Published: February 11, 2022

Primary outcome Measures

  1. evaluate the immunohistochemical expression of Glypican-1 in pleural epitheloid mesothelioma, lung adenocarcinoma and lung SCC [ Time Frame: 1 month ]
    Immunohistochemical study
  2. to correlate its expression with some known clinico-pathological parameters, to evaluate its diagnostic and prognostic role. [ Time Frame: 1 month ]
    Statistical analysis

Inclusion Criteria

  • Patients with pleural epithelioid mesothelioma and lung adenocarcinoma and SCC who underwent surgery

Exclusion Criteria

  • Patients received pre-operative chemotherapy or radiotherapy.
  • Patients with insufficient clinical data.
  • Specimens with extensive necrosis
  • Tiny specimens which are insufficient for accurate diagnosis.
Contact Us
Have you received a diagnosis? *